BlinkLab Limited

BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI App


Australia-based BlinkLab leverages computer vision, artificial intelligence and machine learning by developing an app-enabled, smartphone-based diagnostic tool for evaluating children with neurodevelopmental conditions such as autism and ADHD. The app turns the mobile phone into a medical device for an effortless way of conducting remote and rapid tests.

The BlinkLab Test aims to perform neurobehavioural testing free from facial instruments or other fixed location equipment. This AI-based platform is designed to be used at home or in similar environments, independently or with the assistance of a caregiver while following instructions from the mobile device application.

Blinklab test

In collaboration with Princeton University in the US and Erasmus Medical Center in the Netherlands, Blinklab Test is initially developed as a prescription diagnostic aid to healthcare professionals (HCP). BlinkLab will need to complete a pivotal registrational study and subsequently apply for FDA registration and reimbursement for the tests.

Company Highlights

  • Australia-based BlinkLab is focused on transforming mental healthcare through an AI-enabled smartphone application, a breakthrough technology developed at Princeton University.
  • The company’s innovative approach leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention.
  • Once approved by the regulators, this cutting-edge digital technology is poised to capture the imagination of both investors and major pharmaceutical companies, eager to embrace transformative solutions in healthcare.
  • BlinkLab is led by an experienced management team and leading experts in the field of machine learning, autism and brain development bridging the most advanced technological innovations with groundbreaking scientific research. The company is chaired by Brian Leedman, an experienced biotechnology entrepreneur and founder of ResApp Health, a digital diagnostic company recently acquired by Pfizer.

This BlinkLab is part of a paid investor education campaign.*

Click here to connect with BlinkLab to receive an Investor Presentation

The Conversation (0)
Bar chart.

Tech 5: Apple to Invest US$500 Billion in American Facilities, OpenAI Launches GPT-4.5

Market volatility was on full display this week, beginning with a sharp selloff on Monday (February 24) and exacerbated by a rollout of downbeat economic data, including a weak consumer sentiment report.

Those feelings were echoed in the findings of a Harris Poll conducted for Bloomberg News, which found that nearly 60 percent of US adults expect higher prices in 2025 if President Donald Trump’s policies are enacted.

Rising US jobless claims and fluctuating Personal Consumption Expenditures price index data on Thursday (February 27), coupled with Friday (February 28) numbers showing US consumer spending fell in January and a tense meeting between Trump and Ukrainian President Volodymyr Zelenskyy, intensified economic concerns.

Keep reading...Show less
NVIDIA logo.

NVIDIA Earnings: What Investors Need to Know

NVIDIA's (NASDAQ:NVDA) results have once again exceeded analysts' expectations.

Despite bearish sentiment leading up to the release of its earnings, the company delivered strong results for its fourth fiscal quarter of 2025, driven by the surging demand for its artificial intelligence (AI) solutions.

Quarterly revenue reached US$39.3 billion, a 78 percent increase year-on-year and a 12 percent rise from the previous quarter. Data center revenue soared to US$35.6 billion, up 93 percent from a year ago, highlighting the critical role of NVIDIA's chips in powering the AI revolution. Earnings per diluted share hit US$0.89, surpassing estimates of US$0.85.

Keep reading...Show less
Rocketboots Limited

Appendix 4D & Half Year Report (1H25)

Artificial Intelligence software companyRocketBoots Limited (ASX:ROC) (RocketBoots or the Company) has announced Appendix 4D & Half Year Report (1H25).


Keep reading...Show less
Nanoveu

Binding Share Sale Agreement Executed with EMASS

Nanoveu positioned to accelerate growth in AI-driven edge semiconductor solutions

Nanoveu Limited ("Nanoveu" or the "Company") (ASX: NVU), following on from its announcements on 15 October 2024 and 22 November 2024, is pleased to announce the completion of its binding Share Sale Agreement regarding its 100% acquisition of Embedded A.I. Systems Pte. Ltd. (“EMASS”), a leading System-on-Chip (SoC) semiconductor design company, following shareholder approval and completion of due diligence4. This transaction marks a key strategic moment for Nanoveu and adds cutting edge semiconductor technology to its suite of commercial offerings.

Keep reading...Show less

Latest Press Releases

Related News

×